Why Canopy Growth (TSX:WEED) Is a Buy After the Recent Pullback

Strong liquidity, high growth potential, and initiatives to improve margins make Canopy Growth an attractive buy.

| More on:
Cannabis stocks have fallen.

Canopy Growth (TSX:WEED)(NYSE:CGC) has declined by over 20% since it reported its fourth-quarter earnings on May 29. The lower-than-expected sales and higher EBITDA losses dragged the company’s stock down. Its net losses for the quarter stood at $1.3 billion. The company burnt over $300 million of cash during the quarter. More importantly, the company’s market share declined during the quarter due to a shift in customer preferences towards value products.

Despite these drawbacks, I believe Canopy Growth has strong growth prospects with sufficient capital to support its growth initiatives and move towards profitability.

Canopy’s growth potential

Canopy Growth is focusing on optimizing its product portfolio, expanding its value products, and gaining market share in Cannabis 2.0 product category to drive its sales.

Canopy Growth had too many low-velocity SKUs (stock-keeping units), which were consuming more resources and creating a bottleneck for the supply chain. So, the company has decided to reduce its SKUs to focus more on high-velocity products. This initiative could make the company’s supply chain more agile and aid in meeting customers’ demand.

Over the last few quarters, value products have increased their share in overall cannabis sales. But the company’s market share has declined due to increased competition. So, the company is working on the development of high THC products, optimizing the moisture content in its flower products, and to price its products competitively, which could increase its market share in the value product category.

Despite Canopy Growth’s phased approach toward the introduction of Cannabis 2.0 products, customers have received its products well. The company has already launched four cannabis-infused beverages, two vape product products, and various cannabis-infused chocolates. The company has also planned to introduce new products in the future. During the present quarter, the sales contribution from Cannabis 2.0 products has increased.

BDS Analytics predicts the U.S. CBD market is expected to reach US$20 billion by 2024. However, the market is highly fragmented, providing an excellent opportunity for a company like Canopy Growth to establish its position. The company entered the market in December 2019 through its First & Free brand. Meanwhile, the company is also expanding its product line through its subsidiaries This Works and BioSteel. The company, in collaboration with Martha Stewart, looks to introduce advanced CBD products in this fiscal. So, I am bullish on Canopy Growth’s sales growth prospects.

Initiatives that could improve Canopy’s margin

During the fourth-quarter earnings call, Canopy Growth’s management had announced it will focus on just the top three cannabis markets: the U.S., Canada, and Germany. Meanwhile, in other markets, such as the Asia Pacific and Latin America, the company has implemented an asset-light model.

So, the company has undertaken a series of layoffs in the last few months and expects further cut down on its headcount. The company has reduced its production capacity by 40% to better align its production with the demand. All these initiatives could significantly lower the company’s SG&A (selling, general, and administrative) expenses, and improve its margins. Also, I believe the growth in high-margin Cannabis 2.0 products could support its margin expansion.

Bottom line

With the cannabis sector still in the emerging stage, it provides an excellent opportunity for growth. Meanwhile, cannabis companies have problems raising capital, as the U.S. federal government has classified cannabis under Schedule 1 drug. So, maintaining high liquidity is essential.

At the end of the last quarter, Canopy Growth had $2 billion of gross cash. Given the strong liquidity, high growth potential, and efforts to improve its margins, I believe investors with a long-term horizon should utilize the recent pullback in Canopy Growth stock to accumulate it.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »